Zobrazeno 1 - 10
of 12
pro vyhledávání: '"John D, Wagstaff"'
Publikováno v:
Anesthesia & Analgesia. 104:1514-1520
The synthetic peptide agent Contulakin-G (CGX-1160), isolated from the toxin of the snail Conus geographus, produces significant analgesia in animals. Its peptide structure requires intrathecal administration for effectiveness, therefore we determine
Autor:
Scott J. Low, Baldomero M. Olivera, Grzegorz Bulaj, Doju Yoshikami, T. Patrick Harty, Linda Chicoine, Richard T. Layer, Min Min Zhang, Brian Fiedler, Jacob S. Nielsen, Sue Wei, Heinrich Terlau, Brian D. Klein, John D. Wagstaff, Brad R. Green
Publikováno v:
Biochemistry. 45:7404-7414
μO-Conotoxin MrVIB is a blocker of voltage-gated sodium channels, including TTX-sensitive and -resistant subtypes. A comprehensive characterization of this peptide has been hampered by the lack of sufficient synthetic material. Here, we describe the
Publikováno v:
Brain Research. 721:196-203
The present study was undertaken to examine the role of dopamine D2-receptors in the regulation of neurotensin release. Through a modification of the methods described by Maidment et al. (Neuroscience, 45 (1991) 81–93), we have developed a highly r
Publikováno v:
Brain Research. 665:237-244
Neurotensin (NT) has been proposed to be an endogenous neuroleptic based on observations that i.c.v. administration of this peptide antagonizes dopamine-mediated behavior. Because NT influences dopamine activity, this peptide may contribute to the pa
Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions
Autor:
John D. Wagstaff, James W. Gibb, Glen R. Hanson, Lloyd G. Bush, Nanda A. Singh, Leonora P. Midgley
Publikováno v:
European Journal of Pharmacology. 251:191-199
In this study we evaluated the effects of multiple administrations of selective dopamine D1 and D2 receptor agonists and antagonists on striatal, nigral, accumbens, pallidal and cortical neuropeptide Y systems. Treatment with the D1 receptor agonist,
Autor:
John D. Wagstaff, Tony L. Yaksh, R. Tyler McCabe, Jeffrey W. Allen, Richard T. Layer, Damon McCumber, Katrin Hofer
Publikováno v:
Anesthesia and analgesia. 104(6)
Contulakin-G is a novel conopeptide with an incompletely defined mechanism of action. To assess nociceptive activity we delivered Contulakin-G as a bolus intrathecally (0.03, 0.1, 0.3, 3 nmol) or epidurally (10, 30, 89 nmol) in rats. Intrathecal Cont
Autor:
Grzegorz, Bulaj, Min-Min, Zhang, Brad R, Green, Brian, Fiedler, Richard T, Layer, Sue, Wei, Jacob S, Nielsen, Scott J, Low, Brian D, Klein, John D, Wagstaff, Linda, Chicoine, T Patrick, Harty, Heinrich, Terlau, Doju, Yoshikami, Baldomero M, Olivera
Publikováno v:
Biochemistry. 45(23)
MuO-conotoxin MrVIB is a blocker of voltage-gated sodium channels, including TTX-sensitive and -resistant subtypes. A comprehensive characterization of this peptide has been hampered by the lack of sufficient synthetic material. Here, we describe the
Publikováno v:
Brain research. 1056(2)
The potent NMDA receptor antagonist, Conantokin-G (CGX-1007), a snail peptide, has an 8-h therapeutic window in rat focal cerebral ischemia. We hypothesized that the mechanism of neuroprotection is the inhibition of 'secondary phase' peri-infarct dep
Publikováno v:
Current medicinal chemistry. 11(23)
Conantokins are small peptides (17-27 amino acids) found in the venoms of cone snails (Conus sp.) that inhibit the activity of N-methyl-D-aspartate (NMDA) receptors. Unlike most of the peptides characterized from cone snail venom that contain multipl
Autor:
A Vyazovkina, Lourdes J. Cruz, Grzegorz Bulaj, Doju Yoshikami, James E. Garrett, G O Corpuz, J M McIntosh, Baldomero M. Olivera, John D. Wagstaff, Richard T. Layer
Publikováno v:
The Journal of biological chemistry. 275(42)
Cone snails are tropical marine mollusks that envenomate prey with a complex mixture of neuropharmacologically active compounds. We report the discovery and biochemical characterization of a structurally unique peptide isolated from the venom of Conu